Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2010 2
2014 1
2015 1
2016 2
2017 2
2019 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Covalent Inhibition of the Histamine H3 Receptor.
Wágner G, Mocking TAM, Kooistra AJ, Slynko I, Ábrányi-Balogh P, Keserű GM, Wijtmans M, Vischer HF, de Esch IJP, Leurs R. Wágner G, et al. Molecules. 2019 Dec 11;24(24):4541. doi: 10.3390/molecules24244541. Molecules. 2019. PMID: 31835873 Free PMC article.
New Chemical Biology Tools for the Histamine Receptor Family.
Zheng Y, Wágner G, Hauwert N, Ma X, Vischer HF, Leurs R. Zheng Y, et al. Among authors: wagner g. Curr Top Behav Neurosci. 2022;59:3-28. doi: 10.1007/7854_2022_360. Curr Top Behav Neurosci. 2022. PMID: 35851442
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity.
Wágner G, Mocking TAM, Arimont M, Provensi G, Rani B, Silva-Marques B, Latacz G, Da Costa Pereira D, Karatzidou C, Vischer HF, Wijtmans M, Kieć-Kononowicz K, de Esch IJP, Leurs R. Wágner G, et al. J Med Chem. 2019 Dec 12;62(23):10848-10866. doi: 10.1021/acs.jmedchem.9b01462. Epub 2019 Nov 20. J Med Chem. 2019. PMID: 31675226 Free PMC article.
Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Lead optimization.
Nógrádi K, Wágner G, Domány G, Bobok A, Magdó I, Kolok S, Mikó-Bakk ML, Vastag M, Sághy K, Gyertyán I, Kóti J, Gál K, Farkas S, Keserű GM, Greiner I, Szombathelyi Z. Nógrádi K, et al. Among authors: wagner g. Bioorg Med Chem Lett. 2015 Apr 15;25(8):1724-1729. doi: 10.1016/j.bmcl.2015.02.073. Epub 2015 Mar 7. Bioorg Med Chem Lett. 2015. PMID: 25791451
Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: hit-to-lead optimization.
Nógrádi K, Wágner G, Domány G, Bobok A, Magdó I, Kiss B, Kolok S, Fónagy K, Gyertyán I, Háda V, Kóti J, Gál K, Farkas S, Keserű GM, Greiner I, Szombathelyi Z. Nógrádi K, et al. Among authors: wagner g. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3845-9. doi: 10.1016/j.bmcl.2014.06.057. Epub 2014 Jun 27. Bioorg Med Chem Lett. 2014. PMID: 25017030
Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.
Wágner G, Wéber C, Nyéki O, Nógrádi K, Bielik A, Molnár L, Bobok A, Horváth A, Kiss B, Kolok S, Nagy J, Kurkó D, Gál K, Greiner I, Szombathelyi Z, Keseru GM, Domány G. Wágner G, et al. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3737-41. doi: 10.1016/j.bmcl.2010.04.075. Epub 2010 Apr 22. Bioorg Med Chem Lett. 2010. PMID: 20483612
4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
Galambos J, Domány G, Nógrádi K, Wágner G, Keserű GM, Bobok A, Kolok S, Mikó-Bakk ML, Vastag M, Sághy K, Kóti J, Szakács Z, Béni Z, Gál K, Szombathelyi Z, Greiner I. Galambos J, et al. Among authors: wagner g. Bioorg Med Chem Lett. 2016 Feb 15;26(4):1249-52. doi: 10.1016/j.bmcl.2016.01.024. Epub 2016 Jan 11. Bioorg Med Chem Lett. 2016. PMID: 26774652
14 results